Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Governments need to invest in making assisted reproductive technology more accessible and equitable to counter staggering birth rate declines globally.
A year ago, we adopted an ethics framework to help with the assessment of and to increase transparency and accountability for research practices in studies involving partnerships between researchers in high- and low-income settings. We now reflect on our progress, what we learned and the way forward to champion ethical, inclusive and equitable partnerships in the content we publish.
Incretin-based drugs have demonstrated unprecedented efficacy in weight-loss trials, but ensuring that healthy body weight can be maintained is fundamental to sustainable good health.
The approval of two vaccines and a monoclonal antibody that target respiratory syncytial virus could shift the tide on the prevention and treatment of infection with this virus.
Twenty years after completion of the Human Genome Project, genetics is rapidly being integrated into everyday clinical practice. But in this era of genomic revolution, genetically trained teams of healthcare workers are needed to optimize delivery of patient care.
In this issue, we ask what it takes to build a healthier future for populations — a necessary condition to deliver on the commitments of the United Nations Sustainable Development Goals.
Dietary interventions have the potential to treat a wide variety of chronic conditions and diseases, but generating strong evidence and a framework for their integration into health systems will be critical for their success.
ChatGPT and other large language models may be able to enhance healthcare delivery and patients’ quality of life. But they will need to be tailored to specific clinical needs first.
The international community needs to prioritize research on interventions and preventative measures for dementia that are likely to produce the greatest global impact.
We are launching a series on evidence in medicine, to discuss new approaches to assessing the safety and efficacy of cutting-edge health technologies and treatments.
